Anticancer potentiality of lignan rich fraction of six Flaxseed cultivars
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Ezzat, Shahira M | |
dc.contributor.author | Shouman S.A. | |
dc.contributor.author | Elkhoely A. | |
dc.contributor.author | Attia Y.M. | |
dc.contributor.author | Elsesy M.S. | |
dc.contributor.author | El Senousy A.S. | |
dc.contributor.author | Choucry M.A. | |
dc.contributor.author | El Gayed S.H. | |
dc.contributor.author | El Sayed A.A. | |
dc.contributor.author | Sattar E.A. | |
dc.contributor.author | El Tanbouly N. | |
dc.contributor.other | Pharmacognosy Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | Cairo University | |
dc.contributor.other | Kasr El-Einy Street | |
dc.contributor.other | Cairo | |
dc.contributor.other | 11562 | |
dc.contributor.other | Egypt; Department of Pharmacognosy | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | October University for Modern Science and Arts (MSA) | |
dc.contributor.other | 6th October | |
dc.contributor.other | 12566 | |
dc.contributor.other | Egypt; Cancer Biology Department | |
dc.contributor.other | National Cancer Institute | |
dc.contributor.other | Cairo University | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Pharmacology and Toxicology Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | Helwan University | |
dc.contributor.other | Helwan | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:40:49Z | |
dc.date.available | 2020-01-09T20:40:49Z | |
dc.date.issued | 2018 | |
dc.description | Scopus | |
dc.description | MSA Google Scholar | |
dc.description.abstract | The objective of our study is to highlight the therapeutic effect and mechanism of action by which purified Flaxseed hydrolysate (PFH) which is a lignan rich fraction exerts its anticancer activity on a human breast cancer cell line (T47D) and in mice bearing tumor. HPLC analysis of PFH of six flaxseed cultivars had shown that PFH of the cultivar Giza 9 (PFH-G9) contains the highest concentration of SDG (81.64 mg/g). The in vitro cytotoxic potentiality of PFH's of six flaxseed cultivars was screened against a panel of human cancer cell lines. PFH -G9 showed the most significant cytotoxic activity against ER-receptor positive breast cell lines MCF7 and T47D with IC50 13.8 and 15.8 ?g/ml, respectively. Moreover, PFH-G9 reduced the expression of the metastasis marker, 1-?, metalloproteinases and vascular endothelial growth factor (VEGF), one of the most potent stimulators of angiogenesis, while it increased the caspase-3 dependent apoptosis. Our study also showed that dietary intake of 10% of Giza 9 Flaxseeds (FS), fixed oil (FSO) or Flax meal (FSM) twice daily for 3 weeks in mice-bearing solid Ehrlich ascites carcinoma (EAC) resulted in reducing the tumor volume, the expression of estrogen, insulin growth factor, progesterone, VEGF and MMP-2, but enhanced expression of caspase-3. � 2018 The Author(s). | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=21100200805&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/10.1038/s41598-017-18944-0 | |
dc.identifier.doi | PubMed ID 29323210 | |
dc.identifier.issn | 20452322 | |
dc.identifier.other | https://doi.org/10.1038/s41598-017-18944-0 | |
dc.identifier.other | PubMed ID 29323210 | |
dc.identifier.uri | https://t.ly/P5M8X | |
dc.language.iso | English | en_US |
dc.publisher | Nature Publishing Group | en_US |
dc.relation.ispartofseries | Scientific Reports | |
dc.relation.ispartofseries | 8 | |
dc.subject | antineoplastic agent | en_US |
dc.subject | lignan | en_US |
dc.subject | plant extract | en_US |
dc.subject | tumor marker | en_US |
dc.subject | animal | en_US |
dc.subject | apoptosis | en_US |
dc.subject | chemistry | en_US |
dc.subject | drug effect | en_US |
dc.subject | experimental mammary neoplasm | en_US |
dc.subject | female | en_US |
dc.subject | flax | en_US |
dc.subject | genetics | en_US |
dc.subject | HCT 116 cell line | en_US |
dc.subject | HeLa cell line | en_US |
dc.subject | human | en_US |
dc.subject | MCF-7 cell line | en_US |
dc.subject | metabolism | en_US |
dc.subject | mouse | en_US |
dc.subject | Animals | en_US |
dc.subject | Antineoplastic Agents | en_US |
dc.subject | Apoptosis | en_US |
dc.subject | Biomarkers, Tumor | en_US |
dc.subject | Female | en_US |
dc.subject | Flax | en_US |
dc.subject | HCT116 Cells | en_US |
dc.subject | HeLa Cells | en_US |
dc.subject | Humans | en_US |
dc.subject | Lignans | en_US |
dc.subject | Mammary Neoplasms, Experimental | en_US |
dc.subject | MCF-7 Cells | en_US |
dc.subject | Mice | en_US |
dc.subject | Plant Extracts | en_US |
dc.title | Anticancer potentiality of lignan rich fraction of six Flaxseed cultivars | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Mason, J.K., Thompson, L.U., Flaxseed and its lignan and oil components: Can they play a role in reducing the risk of and improving the treatment of breast cancer? (2014) Appl. Physiol. Nutr. Metab., 39, pp. 663-678; Mali, A.V., In vitro anti-metastatic activity of enterolactone, a mammalian lignan derived from flax lignan, and down-regulation of matrix metalloproteinases in MCF-7 and MDA MB 231 cell lines (2012) Indian J. Cancer., 49, pp. 181-187; Wiseman, H., The bioavailability of non-nutrient plant factors: Dietary flavonoids and phyto-oestrogens. Proceed (1999) Nut. Soc., 58, pp. 139-146; Tou, J.C., Thompson, L., Exposure to flaxseed or its lignan component during different developmental stages influences rat mammary gland structures (1999) Carcinogenesis, 20, pp. 1831-1835; Knight, D.C., Eden, J.A., A review of the clinical effects of phytoestrogens (1996) Obstet. Gynecol., 87, pp. 897-904; Adlercreutz, H., Determination of urinary lignan and phytoestrogen metabolite, potential antiestrogens and anticarcinogens in urine of women on various habitual diets (1986) J. Steroid. Bioch., 25, pp. 791-797; Waldschl�ger, J., Flax-seed extracts with phytoestrogenic effects on a hormone receptor-positive tumor cell line (2005) Anticancer Res., 25, pp. 1817-1822; Yan, L., Yee, J.A., Li, D., McGuire, M.H., Thompson, L.U., Dietary flaxseed supplementation and experimental metastasis of melanoma cells in mice (1998) Cancer Lett., 124, pp. 181-186; Li, D., Yee, J.A., Thompson, L.U., Yan, L., Dietary supplementation with secoisolariciresinol diglycoside (SDG) reduces experimental metastasis of melanoma cells in mice (1999) Cancer Lett., 142, pp. 91-96; Lin, X., Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice (2002) Urology, 60, pp. 919-924; Chen, J., Stavro, P.M., Thompson, L.U., Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor (2002) Nutr. Cancer, 43, pp. 187-192; Thompson, L.U., Rickard, S.E., Orcheson, L.J., Seidl, M.M., Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis (1996) Carcinogensis, 17, pp. 1373-1376; Thompson, L.U., Seidl, M.M., Rickard, S.E., Orcheson, L.J., Fong, H.H., Antitumorigenic effect of a mammalian lignan precursor from flaxseed (1996) Nutr. Cancer, 26, pp. 159-165; Salim, E.I., Abou-Shafey, A.E., Masoud, A.A., Elgendy, S.A., Cancer chemopreventive potential of the Egyptian flaxseed oil in a rat colon carcinogenesis bioassay-implications for its mechanism of action (2011) Asian Pac. J. Cancer Prev., 12, pp. 2385-2392; Dwivedi, C., Natarajan, K., Matthees, D.P., Chemopreventive Effects of Dietary Flaxseed Oil on Colon Tumor Development (2005) Nutr. Cancer, 51, pp. 52-58; Williams, D.S., Chemopreventive effects of Flax seed oil and Flaxseed meal on azoxymethane-induced colon tumors inFisher 344 Male rats. Int (2008) J. Cancer Res., 4, pp. 28-40; Truan, J.S., Chen, J.M., Thompson, L.U., Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen (2010) Mol. Nutr. Food Res., 54, pp. 1414-1421; Boik, J., Natural Compounds in Cancer Therapy (2001) Oregon Medical Press, , Princeton, Minnesota, USA, p. 25; Deryugina, E.I., Quigley, J.P., Matrix metalloproteinases and tumor metastasis (2006) Cancer Metastasis Rev., 25, pp. 29-34; Attia, Y.M., EL-Abhar, H.S., Al Marzabani, M.M., Shouman, S.A., Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines (2015) BMC Cancer, 15, pp. 838-845; Nilsson, U.W., Garvin, S., Dabrosin, C., MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells (2007) Breast Cancer Res. Treat., 102, pp. 253-261; Fang, Y.J., Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colonic cancer cell line HT-29 (2008) Ai Zheng, 27, pp. 1172-1176; De Luca, A., Lamura, L., Gallo, M., Maffia, V., Normanno, N., Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration (2012) J. Cell Biochem., 113, pp. 3363-3370; Liang, Y., Brekken, R.A., Hyder, S.M., Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones (2006) Endocr. Relat. Cancer, 13, pp. 905-919; Bergman, J.M., Thompson, L.U., Dabrosin, C., Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo (2007) Clin. Cancer Res., 13, pp. 1061-1067; Mehlen, P., Puisieux, A., Metastasis: A question of life or death (2006) Nat. Rev. Cancer, 6, pp. 449-458; Maiuri, M.C., Zalckvar, E., Kimchi, A., Kroemer, G., Self-eating and self-killing: Crosstalk between autophagy and apoptosis (2007) Nat. Rev. Mol. Cell Biol., 8, pp. 741-752; Oren, M., Decision making byp53: Life, death and cancer (2003) Cell Death Differ, 10, pp. 431-442; Lee, J., Cho, K., Flaxseed sprouts induce apoptosis and inhibit growth in MCF-7 and MDA-MB-231 human breast cancer cells (2012) In Vitro Cell Dev. Biol. Anim., 48, pp. 244-250; Lim, L.Y., Vidnovic, N., Ellisen, L.W., Leong, C.O., Mutant p53 mediates survival of breast cancer cells (2009) British J. Cancer, 101, pp. 1606-1612; Inwald, E.C., Ki-67 is a prognostic parameter in breast cancer patients: Results of a large population-based cohort of a cancer registry (2013) Breast Cancer Res. Treat., 139, pp. 539-552; �berg, U.W., Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo (2011) PLoS One, 6, p. e25720; Azrad, M., Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer (2013) J. Med. Food, 16, pp. 357-360; Delman, D.M., Fabian, C.J., Kimler, B.F., Yeh, H., Petroff, B.K., Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development (2015) Nutr. Cancer, 67, pp. 857-864; Dupont, J., Le Roith, D., Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: New insights into their synergistic effects (2001) Mol. Pathol., 54, pp. 149-154; Saggar, J.K., Chen, J., Corey, P., Thompson, L.U., The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways (2010) Nutr. Cancer, 62, pp. 533-542; Chen, J., Saggar, J.K., Corey, P., Thompson, L.U., Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice (2009) J. Nutr., 139, pp. 2061-2066; Skehan, P., New colorimetric cytotoxicity assay for anticancer drug screening (1990) J. Natl. Cancer Inst., 82, pp. 1107-1112; Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-??CT (2001) Methods, 25, pp. 402-408; Casciola-Rosen, L., Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death (1996) J. Exp. Med., 183, pp. 1957-1964; Kim, K.J., Li, B., Houck, K., Winer, J., Ferrara, N., The vascular endothelial growth factor proteins: Identification of biologically relevant regions by neutralizing monoclonal antibodies (1992) Growth Factors, 7, pp. 53-64; Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) J. Anal. Biochem., 72, pp. 248-254; Osman, A.M., Sayed-Ahmed, M.M., Khayal, M.T., El-Merzabani, M.M., Hyperthermic potentiation of cisplatin on solid Ehrlich carcinoma (1993) Tumori, 79, pp. 268-272; Ellman, G.L., Tissue sulfhydryl groups (1959) Arch. Biochem. Biophys., 82, pp. 70-77; Draper, H.H., Hadley, M., Malondialdehyde determination as index of lipid peroxidation (1990) Methods Enzymol., 186, pp. 421-431 | |
dcterms.source | Scopus |